EDMONTON, Alberta, June 07, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors were elected to serve for a one-year term at its Annual General and Special Meeting of Shareholders held on June 1, 2022 as per the following results:
Ceapro Announces Results of 2022 Shareholders’ Meeting
/Visa%20Inc%20gold%20card-by%20hatchpong%20via%20iStock.jpg)
